RNAi Roundtable: Revusiran Investigation Results

RNAi Roundtable: Revusiran Investigation Results

On August 9, 2017, we hosted an online RNAi Roundtable to report the findings from the investigation into the ENDEAVOUR Phase 3 trial with revusiran.

View the presentation

Read the transcript

  • John Maraganore, Ph.D., Chief Executive Officer
  • Akshay Vaishnaw, M.D., Ph.D., Executive Vice President of R&D


SIGN UP FOR PATIENT CONNECT

Receive updates on our investigational therapies and clinical trials.